Mini-hepcidins (i.e., short peptides that mimic the activity of endogenous hepcidin) [41] and TMPRSS6 inhibitors [42] showed significant improvements in IE, anemia, and IO in mouse models. This evidence concerns the gene HAMP and anemia (phenotype).